
1. vopr virusol. 2011 may-jun;56(3):20-3.

[immunogenicity inactivated subunit adsorbed monovalent vaccine against
influenza a/california/7/2009 (h1n1) strain].

[article russian]

zverev vv, kostinov mp, mikhailova na, zhirova sn, mironov an, terkacheva oa,
romanova aa, cherdantsev ap.

the immunogenicity pandeflu subunit vaccine influenza
a/california/7/2009 (h1n1) evaluated 70 healthy volunteers aged 18 60
years. vaccine intramuscularly injected twice interval 28 days. 
each dose (0.5 ml) contains a(hin1) influenza virus hemagglutinin (15 +/- 2.2
microg), aluminum hydroxide (denmark) (0.475 +/- 0.075 microg), the
preservative thiomerosal (merthiolate) (50 +/- 7.5 microg). level of
antibodies determined microneutralization assay. administration 
of two doses vaccine 28-day interval, geometric mean antibody
titer (gmat) reached 1:21.1 increase 1:30 (the baseline gmat)
was 1:6.1). frequencies seroconversion seroprotection 71.4 and
59.2%, respectively; antibody increase factor 4.92, meets cpmp 
criteria. administration vaccine result adverse reactions
in postvaccination period.


pmid: 21786622  [indexed medline]

